EUVIMEDEUVIMED entdecken
Vergleichsstudie

Ameliorative Potential of Bone Marrow–Derived Mesenchymal Stem Cells Versus Prednisolone in a Rat Model of Lung Fibrosis: A Histological, Immunohistochemical, and Biochemical Study

Amany Mohamed Shalaby iD, Shaimaa Mohamed Abdelfattah Hassan, Hanim Magdy Abdelnour, Sulaiman Mohammed Alnasser, Mohammed Alorini, Fatima A Jaber, Mohamed Ali Alabiad iD, Asmaa Abdullatif, Mohamed Mahmoud Abdelrahim Elshaer, Seham Ahmed Mohammed Abdel Aziz, Eman M A Abdelghany

Microscopy and Microanalysis · 2024

DOI: 10.1093/mam/ozae043 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Microscopy and Microanalysis, 2024. Verfasst von Amany Mohamed Shalaby und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histology and Cell Biology, Faculty of Medicine, Tanta University, Tanta 31527, Egypt. Hauptthemen laut MEDLINE: Prednisolone, Mesenchymal Stem Cells, Bleomycin, Pulmonary Fibrosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 49 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease of unknown origin with limited treatment options and poor prognosis. The encouraging findings from preclinical investigations utilizing mesenchymal stem cells (MSCs) indicated that they could serve as a promising therapeutic alternative for managing chronic lung conditions, such as IPF. The objective of this study was to compare the efficiency of bone marrow–derived MSCs (BM-MSCs) versus prednisolone, the standard anti-inflammatory medication, in rats with bleomycin (BLM)-induced lung fibrosis. Four groups were created: a control group, a BLM group, a prednisolone-treated group, and a BM-MSCs-treated group. To induce lung fibrosis, 5 mg/kg of BLM was administered intratracheally. BLM significantly increased serum levels of pro-inflammatory cytokines and oxidative stress markers. The disturbed lung structure was also revealed by light and transmission electron microscopic studies. Upregulation in the immune expression of alpha-smooth muscle actin, transforming growth factor beta-1, and Bax was demonstrated. Interestingly, all findings significantly regressed on treatment with prednisolone and BM-MSCs. However, treatment with BM-MSCs showed better results than with prednisolone. In conclusion, BM-MSCs could be a promising approach for managing lung fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PrednisoloneMesenchymal Stem CellsBleomycinPulmonary FibrosisDisease Models, AnimalAnimalsRatsLungImmunohistochemistryMaleCytokinesAnti-Inflammatory AgentsMesenchymal Stem Cell TransplantationHistocytochemistryBone Marrow CellsMicroscopy, Electron, Transmission

Stichwörter der Autor:innen

TGF-β1bleomycinlung fibrosismesenchymal stem cellsα-SMA

Substanzen

PrednisoloneBleomycinCytokinesAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Histology and Cell Biology, Faculty of Medicine, Tanta University, Tanta 31527, Egypt.
  • Department of Histology and Cell Biology, Faculty of Medicine, Menoufia University, Shebin El Koum 32511, Egypt.
  • Department of Anatomy, General Medicine Practice Program, Batterjee Medical College, Aseer 61961, Saudi Arabia.
  • Department of Medical Biochemistry, Faculty of Human Medicine, Zagazig University, 44519Egypt.
  • Department of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Qassim 51452, Saudi Arabia.
  • Department of Pathology, College of Medicine, Qassim University, Unaizah 51911, Saudi Arabia.

ORCID-Profile: Amany Mohamed Shalaby, Mohamed Ali Alabiad

Zitieren

APA

Shalaby, A. M., Hassan, S. M. A., Abdelnour, H. M., Alnasser, S. M., Alorini, M., Jaber, F. A., Alabiad, M. A., Abdullatif, A., Elshaer, M. M. A., Aziz, S. A. M. A., & Abdelghany, E. M. A. (2024). Ameliorative Potential of Bone Marrow–Derived Mesenchymal Stem Cells Versus Prednisolone in a Rat Model of Lung Fibrosis: A Histological, Immunohistochemical, and Biochemical Study. Microscopy and Microanalysis. https://doi.org/10.1093/mam/ozae043

Vancouver

Shalaby AM, Hassan SMA, Abdelnour HM, Alnasser SM, Alorini M, Jaber FA, et al. Ameliorative Potential of Bone Marrow–Derived Mesenchymal Stem Cells Versus Prednisolone in a Rat Model of Lung Fibrosis: A Histological, Immunohistochemical, and Biochemical Study. Microscopy and Microanalysis. 2024. doi:10.1093/mam/ozae043

BibTeX
@article{Shalaby2024,
  author = {Shalaby, Amany Mohamed and Hassan, Shaimaa Mohamed Abdelfattah and Abdelnour, Hanim Magdy and Alnasser, Sulaiman Mohammed and Alorini, Mohammed and Jaber, Fatima A and Alabiad, Mohamed Ali and Abdullatif, Asmaa and Elshaer, Mohamed Mahmoud Abdelrahim and Aziz, Seham Ahmed Mohammed Abdel and Abdelghany, Eman M A},
  title = {Ameliorative Potential of Bone Marrow–Derived Mesenchymal Stem Cells Versus Prednisolone in a Rat Model of Lung Fibrosis: A Histological, Immunohistochemical, and Biochemical Study},
  journal = {Microscopy and Microanalysis},
  year = {2024},
  doi = {10.1093/mam/ozae043}
}
Kostenlos starten →